The role of serotonin in panic, anxiety and depression

International Clinical Psychopharmacology

Volumn 13, Issue SUPPL. 4, 1998, Pages

  Deakin, J F William ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Anxiety; Depression; Panic disorder; Serotonin

Indexed keywords

BENZODIAZEPINE; BUSPIRONE; DIAZEPAM; FENFLURAMINE; FLUVOXAMINE; RITANSERIN; SEROTONIN; SEROTONIN 1A AGONIST; SEROTONIN 2 ANTAGONIST; SEROTONIN UPTAKE INHIBITOR;

ANIMAL MODEL; ANXIETY NEUROSIS; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; HUMAN; MAJOR CLINICAL STUDY; MENTAL DISEASE; NONHUMAN; PANIC; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RAT; REVIEW; SEROTONIN RELEASE; SEROTONINERGIC SYSTEM;

ADAPTATION, PSYCHOLOGICAL; ANIMALS; ANXIETY DISORDERS; BRAIN; DEPRESSIVE DISORDER; HUMANS; PANIC DISORDER; SEROTONIN; SEROTONIN UPTAKE INHIBITORS;

EID: 0031815074     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Ashcroft KR, Guimaraes FS, Wang M, Deakin JFW (1991). Evaluation of a psychophysiological model of classical fear conditioning in anxious patients. Psychopharmacology 104:215-219.
2. Ceulemans DL, Hoppenbrouwers ML, Gelders YG, Reyntjens AJ (1985). The influence of ritanserin, a serotonin antagonist, in anxiety disorders: a double-blind placebo-controlled study versus lorazepam. Pharmacopsychiatry 18:303-305.
3. 1A agonists in anxiety and depression. J Psychopharmacol 7:283-289.
4. Deakin JFW (1996). 5-HT antidepressant drugs and the psychosocial origins of depression. J Psychopharmacol 10:31-38.
5. Deakin JFW, Graeff FG (1991). 5-HT and mechanisms of defence. J Psychopharmacol 5:305-315.
6. Deakin JF, Pennell I, Upadhyaya AJ, Lofthouse R (1990).A neuroendocrine study of 5-HT function in depression: evidence for biological mechanisms of endogenous and psychosocial causation. Psychopharmacology (Berl) 101:85-92.
7. Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger GR (1990). Serotonin function and the mechanism of antidepressant action: reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan.Arch Gen Psychiatry 47:411-418.
8. Den Boer JA, Westenberg HG (1990). Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin. Psychopharmacology (Berl) 102:85-94.
9. Gammans RE, Stringfellow JC, Hvizdos AJ, Seidehamel RJ, Cohn JB, Wilcox CS, et al. (1992). Use of buspirone in patients with generalized anxiety disorder and coexisting depressive symptoms: a meta-analysis of eight randomized, controlled studies. Neuropsychobiology 25:193-201.
10. Goldberg D (1996). A dimensional model for common mental disorders. Br J Psychiatry 30:44-49.
11. Guimaraes FS, Kohem CL, Gus G, Fillmann HS, de Vecino MC, de Paoli CL, et al. (1989). A simple simulated public speaking test for evaluating anxiolytic drugs. Braz J Med Biol Res 22:1083-1089.
12. Hetem LA, de Souza CJ, Guimaraes FS, Zuardi AW, Graeff FG (1993). D-fenfluramine reduces anxiety induced by simulated public speaking. Braz J Med Biol Res 26:971-974.
13. Kendler KS, Walters EE, Neale MC, Kessler RC, Heath AC, Eaves LJ (1995).The structure of the genetic and environmental risk factors of six major psychiatric disorders in women: phobia, generalized anxiety disorder, panic disorder, bulimia, major depression and alcoholism. Arch Gen Psychiatry 52:374-383.
14. Kennett GA, Dickinson S, Curzon G (1985). Enhancement of some 5-HT-dependent behavioural responses following repeated immobilization in rats. Brain Res 330:253-263.
15. Mongeau R, Blier P, de Montigny C (1997). The serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments. Brain Res Brain Res Rev 23:145-195.
16. Perna G, Caldirola D, Arancio C, Bellodi L (1997). Panic attacks: a twin study. Psychiatry Res 66:69-71.
17. 1A partial agonists in depression: a composite analysis of buspirone in the treatment of depression. J Clin Psychopharmacol 10 (suppl 3):S67-S76.
18. Sheehan DV, Raj AB, Harnett-Sheehan K, Soto S, Knapp E (1993). The relative efficacy of high-dose buspirone and alprozolam in the treatment of panic disorder: a double-blind placebo-controlled study. Acta Psychiatr Scand 88:1-11.
19. Woods SW, Charney DS, Goodman WK, Heninger GR (1988). Carbon dioxide-induced anxiety. Behavioural, physiologic, and biochemical effects of carbon dioxide in patients with panic disorders and healthy subjects. Arch Gen Psychiatry 45:43-52.